Want to see MRAI full AI Analyst Report?
MRAI Stock Chart & Stats
$2.25
-$0.13(-5.49%)
At close: 4:00 PM EDT
$2.25
-$0.13(-5.49%)
Day’s Range― - ―
52-Week Range$0.22 - $3.05
Previous CloseN/A
Volume67.54K
Average Volume (3M)71.44K
Market Cap
$81.29M
Enterprise Value$25.73
Total Cash (Recent Filing)$138.00K
Total Debt (Recent Filing)$662.00K
Price to Earnings (P/E)―
Beta-0.77
Next Earnings
Nov 16, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.77
Shares Outstanding26,829,834
10 Day Avg. Volume72,215
30 Day Avg. Volume71,443
Financial Highlights & Ratios
PEG Ratio0.01
Price to Book (P/B)-0.34
Price to Sales (P/S)0.61
P/FCF Ratio-1.47
Enterprise Value/Market Cap<0.01
Enterprise Value/Revenue<0.01
Enterprise Value/Gross Profit<0.01
Enterprise Value/Ebitda>-0.01
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Recurring TPA Revenue ModelRecurring fees for plan administration, eligibility, claims support, member service and related programs provide a repeatable revenue model. Client retention and additional contracted services could support durable revenue visibility as Marpai serves employer-sponsored health plans.
Debt RestructuringLower near-term debt service can preserve cash for operations, technology development and market expansion. Extending maturities also gives management more time to improve the business before major obligations become due, increasing financial flexibility.
Growth FinancingThe $12 million preferred financing adds capital to support Marpai’s healthcare services platform and growth plans. Additional funding may provide resources for operations and expansion while reducing immediate reliance on internally generated cash, which remains negative.
Bears Say
Revenue And Profitability WeaknessSharp revenue contraction and gross profit near breakeven indicate that the current operating base is not producing sufficient economic value. Extremely negative margins leave little buffer for execution setbacks and make a sustained path to profitability dependent on material improvement.
Persistent Cash BurnConsistently negative operating and free cash flow show that the business is not funding its operations from recurring activity. Continued cash burn increases dependence on external capital or balance-sheet resources and could constrain investment if profitability does not improve.
Negative Equity And Shrinking Asset BaseDeeply negative equity reflects accumulated losses and reduces financial flexibility, while a smaller asset base means fewer resources support the business. Together, these conditions weaken resilience and can complicate future financing, investment and balance-sheet management.
Marpai News
MRAI FAQ
What was Marpai’s price range in the past 12 months?
Marpai lowest stock price was $0.21 and its highest was $3.05 in the past 12 months.
What is Marpai’s market cap?
Marpai’s market cap is $81.29M.
When is Marpai’s upcoming earnings report date?
Marpai’s upcoming earnings report date is Nov 16, 2026 which is in 70 days.
How were Marpai’s earnings last quarter?
Marpai released its earnings results on Aug 13, 2026. The company reported -$0.177 earnings per share for the quarter.
Is Marpai overvalued?
According to Wall Street analysts Marpai’s price is currently Overvalued.
Does Marpai pay dividends?
Marpai does not currently pay dividends.
What is Marpai’s EPS estimate?
Marpai’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Marpai have?
Marpai has 26,829,834 shares outstanding.
What happened to Marpai’s price movement after its last earnings report?
Marpai reported an EPS of -$0.177 in its last earnings report. Following the earnings report the stock price went up 0.913%.
Which hedge fund is a major shareholder of Marpai?
Currently, no hedge funds are holding shares in MRAI
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Marpai Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Positive
20 days / 200 days
Momentum
124.44%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
-14.41%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Marpai
Marpai, Inc. operates as a technology-driven healthcare payer, concentrating its efforts on the self-insured employer market within the United States and Israel. The firm provides a comprehensive suite of supplementary services, which includes managing patient care and individual cases, actuarial evaluations, administering health savings accounts, and implementing cost-saving measures. Additionally, Marpai innovates in artificial intelligence and healthcare technology. These advanced platforms process data to anticipate and preempt issues such as diagnostic inaccuracies, preventable hospitalizations, and administrative inefficiencies. Incorporated in 2021, the company's main office is situated in New York, New York.
Technical Analysis
Ownership Overview
61.43% Insiders
0.08% Other Institutional Investors
38.49% Public Companies and
Individual Investors